Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6,401,869
-
Total 13F shares
-
231,967
-
Share change
-
+211,818
-
Total reported value
-
$268,673
-
Price per share
-
$1.16
-
Number of holders
-
11
-
Value change
-
+$237,604
-
Number of buys
-
8
-
Number of sells
-
5
Institutional Holders of MAINZ BIOMED N.V. - Common Stock (MYNZ) as of Q4 2023
As of 31 Dec 2023,
MAINZ BIOMED N.V. - Common Stock (MYNZ) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
231,967 shares.
The largest 10 holders included
PRELUDE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, Vontobel Holding Ltd., XTX Topco Ltd, Greenwich Investment Management, Inc., NewEdge Advisors, LLC, and CITIGROUP INC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.